Nereid Therapeutics
PrivateLast Round
Series A
Nov 16, 2020
Total Funding Raised
$50M
Company Overview
Nereid Therapeutics is a biotechnology company that develops small molecule therapeutics for cancer, neurodegenerative disorders, and inflammatory diseases by leveraging proprietary technologies to study liquid-liquid phase separation and biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nereid Therapeutics Comparables
Compare Nereid Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transition Bio | 92% | |
| Dewpoint Therapeutics | 91% | |
| Aquinnah Pharmaceuticals | 88% | |
Nereid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 16, 2020 |
Nereid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 16, 2020
$50M round led by Apple Tree Partners
Nereid Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nereid Therapeutics's valuation, stock price, and market status.